{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-004107","form_type":"8-K","ticker":"SLS","cik":"0001390478","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2025-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.502180+00:00","generated_at":"2026-05-27T23:52:30.269534+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"medium","headline":"SELLAS Life Sciences amends severance agreements for two officers to 15 months base salary upon change of control","bullets":["Board approved amendments to change-in-control severance agreements for SVP/Chief Development Officer Dragan Cicic and SVP/CFO John Burns.","Amendments provide for severance of 15 months of then-current base salary upon termination in connection with a change of control.","Original agreements were dated December 14, 2021; other provisions remain unchanged.","Full text of amendments to be filed in next periodic report."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-004107","json":"https://secwatch.observer/filing/0001104659-25-004107.json","markdown":"https://secwatch.observer/filing/0001104659-25-004107.md","text":"https://secwatch.observer/filing/0001104659-25-004107.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925004107/0001104659-25-004107-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465925004107/tm253479d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T23:52:30.269534+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}